DILIsym Services is a leading provider of drug-induced liver injury simulation software and consulting services to the pharmaceutical industry. Their DILIsym software helps pharmaceutical companies assess the potential liver toxicity of new drugs during the development process. By simulating the effects of different molecules on the liver, the software provides a deeper understanding of the mechanisms responsible for liver injury. Founded in 2015, DILIsym Services acquired all the necessary intellectual property and materials from the former Hamner Institutes. Their software and consulting services are aimed at ensuring the safety of drug therapies and improving the drug development process.